Cannabis Control Commission Public Meeting
February 6, 2020
10:00 a.m.
Location:
Cannabis Control Commission
Worcester Union Station
2 Washington Square
Worcester, MA, 01604
Public Meeting Agenda
1) Call to Order
2) Chairman’s Comments & Updates
3) Approval of Minutes
4) Executive Director’s Report
a. Social Equity Program Update
b. Regulatory Timeline
5) Staff Recommendations on Changes of Ownership
a. Hope Heal Health, Inc.
b. MassMedicum Corp.
6) Staff Recommendations on Renewals
a. Baked Bean, LLC. (#MPR243509), Product Manufacturer Renewal
b. Solar Therapeutics, Inc. (#MCR139862), Cultivation Renewal
c. Holyoke Gardens, LLC. (#MCR139861), Cultivation Renewal
d. Rise Holdings, Inc., (#MRR205560) Retailer Renewal
e. Liberty Compassion, Inc., Vertically-Integrated Medical Marijuana Treatment Center Renewal
7) Staff Recommendations on Final Licenses
a. Blackstone Valley Naturals, LLC (#MB281476), Microbusiness
b. Caregiver-Patient Connection (#MR282131), Retailer
c. Curaleaf Massachusetts, Inc. (#MR282183), Retailer
d. Green Biz, LLC. (#MR281793), Retailer
e. Ipswich Pharmaceutical Associates, Inc. (#MR281571), Retailer
f. Nova Farms, LLC. (#MR281379), Retailer
g. Pioneer Valley Extracts, LLC (#MP281417), Product Manufacturer
h. Pure Oasis, LLC (#MR281352), Retailer
i. Solar Therapeutics (#MP281464), Product Manufacturer
j. The Verb is Herb (#MR281637), Retailer
k. Bountiful Farms (#RMD-1485), Vertically-Integrated Medical Marijuana Treatment Center
l. Resinate, Inc. (#RMD-1345), Vertically-Integrated Medical Marijuana Treatment Center
8) Staff Recommendations on Provisional Licenses
a. Apothca, Inc. (#MRN282730), Retailer
b. Cultivate Holdings, LLC. (#MCN282053), Cultivation, Tier 5 / Indoor
c. Cultivate Holdings, LLC. (#MPN281742), Product Manufacturer
d. Diem Orange, LLC. (#MCN282161), Cultivation, Tier 2 / Indoor
e. Diem Orange, LLC. (#MPN281684), Product Manufacturer
f. Grass Appeal, LLC. (#MCN282123), Cultivation, Tier 3 / Indoor
g. Grass Appeal, LLC. (#MRN282267), Retailer
h. Greenstar Herbals, Inc. (#MRN282207), Retailer
i. Heka, Inc. (#MCN282248), Cultivation, Tier 4 / Indoor
j. Heka, Inc. (#MPN281736), Product Manufacturer
k. Heka, Inc. (#MRN282770), Retailer
l. Heka, Inc. (#MRN282903), Retailer
m. Holistic Industries, Inc. (#MRN282605), Retailer
n. M3 Ventures, Inc. (#MRN282350), Retailer
o. Olde World Remedies, Inc. (#MRN282742), Retailer
p. Pharmacannis Massachusetts, Inc. (#MCN282047), Cultivation, Tier 7 / Indoor
q. Platinum Hydrolab, Inc. (#MCN281510), Cultivation, Tier 1 / Indoor
r. Platinum Hydrolab, Inc. (#MPN281540), Product Manufacturer
s. Resinate, Inc. (#MCN281259), Cultivation, Tier 3 / Indoor
t. Resinate, Inc. (#MPN281753), Product Manufacturer
u. Resinate, Inc. (#MRN281249), Retailer
v. Resinate, Inc. (#MRN282398), Retailer
w. Riverrun Gardens, LLC. (#MBN281332), Microbusiness (Cultivation Only)
x. The Botanist, Inc. (#MRN282160), Retailer
y. The Botanist, Inc. (#MRN282186), Retailer
z. The Heirloom Collective, Inc. (#MRN283029), Retailer
aa. Western Front, LLC (#MRN281907), Retailer
9) Commission Discussion and Votes
a. Diversity Plans and Best Practices
b. Election of Commission Secretary and Commission Treasurer
c. Research Report: Market Data & Industry Participation
10) New Business that the Chairman did not anticipate at time of posting
11) Next Meeting Date
12) Executive Session
13) Adjournment
Notice of Executive Session
Under the Open Meeting Law, G.L. c. 30A, § 21(a)(2), (4) and (7) and the Public Records Law, G.L. c. 66, and the exemptions set forth in G.L. c. 4, § 7(26)(a), (b), (c), (d), (f), (g) and (n), the Commission may enter into executive session to discuss the following items if the relevant topic arises during the course of deliberations:
1) to discuss applicants’ or provisional licensees’ security plans if, in the opinion of the Chair, discussion of such plans in an open meeting may disclose information that could pose a risk to public safety or security; and
2) Under the Open Meeting Law, G.L. c. 30A, § 21(a)(3) and (7) and the Public Records Law, G.L. c. 66, and the exemptions set forth in G.L. c. 4, § 7(26)(d), the Commission may enter into executive session to discuss litigation and policy matters related to the matter of Revolutionary Clinics II, Inc. v. City of Cambridge pending before the Middlesex Superior Court.
Statement of Chair’s Authority
Under the Open Meeting Law, G.L. c. 30A, §20(g):
No person shall address a meeting of a public body without permission of the chair, and all persons shall, at the request of the chair, be silent. No person shall disrupt the proceedings of a meeting of a public body. If, after clear warning from the chair, a person continues to disrupt the proceedings, the chair may order the person to withdraw from the meeting and if the person does not withdraw, the chair may authorize a constable or other officer to remove the person from the meeting.
In order that the Commission may conduct the business duly before it as delineated in this agenda, the Chair shall exercise his discretion accordingly. Please respect fellow attendees and those with business before the Commission.
